| For: | Du B, Yang ZY, Zhong XY, Fang M, Yan YR, Qi GL, Pan YL, Zhou XL. Metastasis-associated protein 1 induces VEGF-C and facilitates lymphangiogenesis in colorectal cancer. World J Gastroenterol 2011; 17(9): 1219-1226 [PMID: 21448429 DOI: 10.3748/wjg.v17.i9.1219] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i9/1219.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Chao Chen, Jian Wang, Binjie Sun, Yuyan Zheng, Xiaoxu Ge, Zhiyuan Gong, Haochen Gu, Zhiwei Zhang, Akao Zhu, Yingkuan Shao, Yeting Hu, Lijia Ma, Yini Li, Kefeng Ding, Da Wang, Lifeng Sun. The heterogeneity of genomic alterations, metastatic patterns and immune microenvironment in metastatic ovarian cancer originating from colorectal cancer. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1593439
|
| 3 |
Ansgar Brüning, Thomas Blankenstein, Julia Jückstock, Ioannis Mylonas. Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive system. Cancer and Metastasis Reviews 2014; 33(4) doi: 10.1007/s10555-014-9520-6
|
| 4 |
Xiangyi Kong, XiaoFeng Xu, Yuhua Yan, Feifei Guo, Jian Li, Yali Hu, Huaijun Zhou, Qingying Xun, Moray Campbell. Estrogen Regulates the Tumour Suppressor MiRNA-30c and Its Target Gene, MTA-1, in Endometrial Cancer. PLoS ONE 2014; 9(3) doi: 10.1371/journal.pone.0090810
|
| 5 |
Aishwarya S. Iyer, Mohammed Rifat Shaik, Jean-Pierre Raufman, Guofeng Xie. The Roles of Zinc Finger Proteins in Colorectal Cancer. International Journal of Molecular Sciences 2023; 24(12) doi: 10.3390/ijms241210249
|
| 6 |
Wolf H. Fridman, Ian Miller, Catherine Sautès-Fridman, Annette T. Byrne. Therapeutic Targeting of the Colorectal Tumor Stroma. Gastroenterology 2020; 158(2) doi: 10.1053/j.gastro.2019.09.045
|
| 7 |
Deivendran Sankaran, Suresh B. Pakala, Vasudha S. Nair, Divijendra Natha Reddy Sirigiri, Dinesh Cyanam, Ngoc-Han Ha, Da-Qiang Li, T.R. Santhoshkumar, M. Radhakrishna Pillai, Rakesh Kumar. Mechanism of MTA1 Protein Overexpression-linked Invasion. Journal of Biological Chemistry 2012; 287(8) doi: 10.1074/jbc.M111.324632
|
| 8 |
FENG JIAO, ZILIANG JIN, LEI WANG, LIWEI WANG. Research and clinical applications of molecular biomarkers in gastrointestinal carcinoma (Review). Biomedical Reports 2013; 1(6) doi: 10.3892/br.2013.158
|
| 9 |
Yan-Fang Yu, Yong Zhang, Na Shen, Rui-Ying Zhang, Xin-Qing Lu. Effect of VEGF, P53 and telomerase on angiogenesis of gastric carcinoma tissue. Asian Pacific Journal of Tropical Medicine 2014; 7(4) doi: 10.1016/S1995-7645(14)60041-9
|
| 10 |
Ekjot Kaur, Sudeep Gupta, Shilpee Dutt. Clinical implications of MTA proteins in human cancer. Cancer and Metastasis Reviews 2014; 33(4) doi: 10.1007/s10555-014-9527-z
|
| 11 |
Guo-dong Cao, Bo Chen, Mao-ming Xiong, Alberto Ocaña. Role of metastasis-associated protein 1 in prognosis of patients with digestive tract cancers: A meta-analysis. PLOS ONE 2017; 12(6) doi: 10.1371/journal.pone.0176431
|
| 12 |
Rui-Cheng Ji. Hypoxia and lymphangiogenesis in tumor microenvironment and metastasis. Cancer Letters 2014; 346(1) doi: 10.1016/j.canlet.2013.12.001
|
| 13 |
Caren Jayasinghe, Nektaria Simiantonaki, Sylvia Habedank, Charles James Kirkpatrick. The relevance of cell type- and tumor zone-specific VEGFR-2 activation in locally advanced colon cancer. Journal of Experimental & Clinical Cancer Research 2015; 34(1) doi: 10.1186/s13046-015-0162-5
|
| 14 |
Jaume Capdevila, Alfredo Carrato, Josep Tabernero, Enrique Grande. What could Nintedanib (BIBF 1120), a triple inhibitor of VEGFR, PDGFR, and FGFR, add to the current treatment options for patients with metastatic colorectal cancer?. Critical Reviews in Oncology/Hematology 2014; 92(2) doi: 10.1016/j.critrevonc.2014.05.004
|
| 15 |
Anait S. Levenson, Avinash Kumar, Xu Zhang. MTA family of proteins in prostate cancer: biology, significance, and therapeutic opportunities. Cancer and Metastasis Reviews 2014; 33(4) doi: 10.1007/s10555-014-9519-z
|
| 16 |
Jianping Liu, Juan Xia, Yongheng Zhang, Maoyong Fu, Sheng Gong, Yulong Guo. Associations between the expression of MTA1 and VEGF-C in esophageal squamous cell carcinoma with lymph angiogenesis and lymph node metastasis. Oncology Letters 2017; 14(3) doi: 10.3892/ol.2017.6530
|
| 17 |
Shaoqi Zong, Hongjia Li, Qi Shi, Shanshan Liu, Wen Li, Fenggang Hou. Prognostic significance of VEGF-C immunohistochemical expression in colorectal cancer: A meta-analysis. Clinica Chimica Acta 2016; 458 doi: 10.1016/j.cca.2016.04.037
|
| 18 |
Jian Liu, Haijuan Wang, Changzhi Huang, Haili Qian. Subcellular localization of MTA proteins in normal and cancer cells. Cancer and Metastasis Reviews 2014; 33(4) doi: 10.1007/s10555-014-9511-7
|
| 19 |
Tianbo Liu, Ming Yang, Shanshan Yang, Tingting Ge, Lina Gu, Ge Lou. Metastasis-associated protein 1 is a novel marker predicting survival and lymph nodes metastasis in cervical cancer. Human Pathology 2013; 44(10) doi: 10.1016/j.humpath.2013.05.009
|
| 20 |
Ke Ma, Yangwei Fan, Yuan Hu. Prognostic and clinical significance of metastasis-associated gene 1 overexpression in solid cancers. Medicine 2018; 97(41) doi: 10.1097/MD.0000000000012292
|
| 21 |
Anait S. Levenson. Metastasis-associated protein 1-mediated antitumor and anticancer activity of dietary stilbenes for prostate cancer chemoprevention and therapy. Seminars in Cancer Biology 2022; 80 doi: 10.1016/j.semcancer.2020.02.012
|
| 22 |
Seda Tuncay Cagatay, Ismail Cimen, Berna Savas, Sreeparna Banerjee. MTA-1 expression is associated with metastasis and epithelial to mesenchymal transition in colorectal cancer cells. Tumor Biology 2013; 34(2) doi: 10.1007/s13277-013-0662-x
|
| 23 |
Zhaoliang Hu, Xushi Zhao, Zhonghua Wu, Bicheng Qu, Minxian Yuan, Yanan Xing, Yongxi Song, Zhenning Wang. Lymphatic vessel: Origin, heterogeneity, biological functions and therapeutic targets. Signal Transduction and Targeted Therapy 2024; 9(1) doi: 10.1038/s41392-023-01723-x
|
| 24 |
Xiaomeng Dai, Mao Fang, Shuang Li, Yongrong Yan, Ying Zhong, Bin Du. miR‑21 is involved in transforming growth factor β1‑induced chemoresistance and invasion by targeting PTEN in breast cancer. Oncology Letters 2017; doi: 10.3892/ol.2017.7007
|
| 25 |
Wen-Fei Li, Na Liu, Rui-Xue Cui, Qing-Mei He, Mo Chen, Ning Jiang, Ying Sun, Jing Zeng, Li-Zhi Liu, Jun Ma. Nuclear overexpression of metastasis-associated protein 1 correlates significantly with poor survival in nasopharyngeal carcinoma. Journal of Translational Medicine 2012; 10(1) doi: 10.1186/1479-5876-10-78
|
| 26 |
Yahong Wu, Wenjie Zhai, Xiuman Zhou, Zhiwei Wang, Yan Lin, Ling Ran, Yuanming Qi, Yanfeng Gao. HLA-A2-Restricted Epitopes Identified from MTA1 Could Elicit Antigen-Specific Cytotoxic T Lymphocyte Response. Journal of Immunology Research 2018; 2018 doi: 10.1155/2018/2942679
|
| 27 |
Vijaya Lakshmi Malisetty, Vasudevarao Penugurti, Prashanth Panta, Suresh Kumar Chitta, Bramanandam Manavathi. MTA1 expression in human cancers – Clinical and pharmacological significance. Biomedicine & Pharmacotherapy 2017; 95 doi: 10.1016/j.biopha.2017.09.025
|
| 28 |
Yasushi Toh, Garth L. Nicolson. Trends in Stem Cell Proliferation and Cancer Research. 2013; doi: 10.1007/978-94-007-6211-4_10
|
| 29 |
Pengping Li, Wei Cao, Rui Ding, Mengqiu Cheng, Xin Xu, Sihan Chen, Bo Chen, Guodong Cao, Maoming Xiong. Expression and Prognostic Significance of Metastasis-Associated Protein 1 in Gastrointestinal Cancer. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.542330
|
| 30 |
Yasushi Toh, Garth L. Nicolson. Properties and clinical relevance of MTA1 protein in human cancer. Cancer and Metastasis Reviews 2014; 33(4) doi: 10.1007/s10555-014-9516-2
|